Pennant Group (PNTG) - Narxning prognoz qilingan daromadga nisbati

Ommaviy kompaniya pennantgroup.com (PNTG) logotipi

The Pennant Group, Inc. (PNTG) rahbariyati o'sishni tezlashtirish uchun mahalliy agentliklarni sotib oluvchi faol serial konsolidator sifatida ish olib bormoqda. Kutilayotgan daromad ko'paytirgichi ushbu kengayish natijalarini aks ettiradi, bunda ko'rsatkich qiymati 0.70 ni tashkil etadi. Strategiya aholining qarishi fonida xospislar va parvarish xizmatlarini konsolidatsiya qilishga asoslangan. Kompaniya Medicare/Medicaid davlat dasturlari va tibbiy reabilitatsiya uchun sug'urta to'lovlari orqali daromad keltiradi.

The Pennant Group - PNTG Bozor kapitallashuvining kelajakdagi daromadga nisbati (davr: 04.07.2022 - 15.11.2026)

The Pennant Group, Inc. - tahliliy kesimlar va asosiy koʻrsatkichlar (PNTG)

Kompaniyaning fundamental tahlili:PNTG (The Pennant Group, Inc.)
The Pennant Group Corp original mahsuloti

Forward P/S biznesning bozor qiymatini kutilayotgan savdo hajmi bilan nisbatda belgilaydi va potentsial o'sish uchun premiumni o'lchaydi. The Pennant Group, Inc. (PNTG) uchun ushbu koeffitsient ESG standartlarining joriy etilishi va kliniklarda bio-chiqindilardan foydalanishni optimallashtirishning monetizatsiyasini aks ettiradi. Forward P/S ni tahlil qilish orqali investor aktiv haddan tashqari sotib olinganmi yoki yashirin o'sish potentsialiga egami, shuni aniqlashi mumkin. Indikatorning tendentsiyasi fundamental barqarorlikni va kapitalni boshqarish sifatini tasdiqlaydi.

The Pennant Group, Inc. raqobatchilari tahlili

Forvard P/S multiplikatori HCA (HCA Healthcare, Inc.)|Narxning kutilayotgan daromadga nisbati THC (Tenet Healthcare)|FMS - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati solventum.com|EHC: Forvard P/S multiplikatori|UHS - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|DVA (DaVita Corp) - Forvard P/S multiplikatori|RDNT: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori OPCH|SGRY (surgerypartners.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori PINC (Premier Inc)|National Vision - Narxning prognoz qilingan daromadga nisbati|PGNY - Narxning prognoz qilingan daromadga nisbati|ARDT - Forvard P/S multiplikatori|SEM: Forvard P/S multiplikatori|astranahealth.com (ASTH) - Forvard P/S multiplikatori|MD (mednax.com) - Forvard P/S multiplikatori|Forvard P/S multiplikatori usph.com|Narxning prognoz qilingan daromadga nisbati Organogenesis Corp (ORGO)|NUTX (Nutex Health Corp) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori AUNA (Auna S.A.)|SBC Medical Group Holdings Inc (SBC) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|EOLS - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx CYH (Community Health Systems Inc)|SKIN (beautyhealth.com) - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati MDWD|Narxning prognoz qilingan daromadga nisbati biote Corp.|Bozor kapitallashuvining kelajakdagi daromadga nisbati thejoint.com JYNT|Forvard P/S multiplikatori DCGO|Forvard narx/daromad multiplikatori P3 Health PIII|Forvard P/S multiplikatori GANX (Gain Therapeutics Inc.)|Forvard P/S multiplikatori EUDA Health Holdings Limited EUDA|baselmedical.com - Forvard P/S multiplikatori|CLGN: Narxning prognoz qilingan daromadga nisbati|Cuprina Holdings (Cayman) Ltd. (CUPR) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Concord Medical|AMS (American Shared Hospital Services Inc) - Forvard P/S multiplikatori|MEDIROM Corp (MRM) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori ALBT|Kapitalizatsiyaning kutilayotgan sotuvga nisbati DIH Holding|Forvard P/S multiplikatori XAGE (carmellcosmetics.com)|NIVF: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|ATIP: Forvard narx/daromad multiplikatori|CareMax Medical Group - Narxning kutilayotgan daromadga nisbati|Kindly MD (KDLY) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati MODV|Narxning prognoz qilingan daromadga nisbati Novo Integrated Sciences Corp|Bozor kapitallashuvining kelajakdagi daromadga nisbati SunLink Health Systems SSY|Narxning prognoz qilingan daromadga nisbati IMAC Corp (BACK)